Mylan Says It Will Expand Programs That Lower EpiPen CostsMylan, now in the crosshairs over severe price hikes for its EpiPen, says it will expand programs that lower out-of-pocket costs by as much as half.
Congress Unites In Scorn For Shkreli, But Gridlock RemainsWashington lawmakers took turns blasting a price-hiking former CEO who has become the new poster child for corporate greed.
Seniors & The ACA

More From CBS Dallas / Fort Worth

Drip Pan: CBS Local App
Drip Pan: Weather App

Listen Live